Fay, J W <br/><br/>
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.  [electronic resource] 

 -  Blood  Apr 1996 
 - 3514-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Biological Availability<br/>Bone Marrow Transplantation--adverse effects<br/>Chemical and Drug Induced Liver Injury<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--epidemiology<br/>Histocompatibility<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Incidence<br/>Kidney Diseases--chemically induced<br/>Leukemia--mortality<br/>Life Tables<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--mortality<br/>Nuclear Family<br/>Parity<br/>Safety<br/>Survival Analysis<br/>Tacrolimus--administration & dosage<br/>Tissue Donors<br/>Transplantation, Homologous--adverse effects<br/>Treatment Outcome